Authors:
Hashimoto, E
Shimada, M
Noguchi, S
Taniai, M
Tokushige, K
Hayashi, N
Takasaki, K
Fuchinoue, S
Ludwig, J
Citation: E. Hashimoto et al., Disease recurrence after living liver transplantation for primary biliary cirrhosis: A clinical and histological follow-up study, LIVER TRANS, 7(7), 2001, pp. 588-595
Citation: H. Osono et al., Thermal generation of vacancies in high-quality aluminium crystals (vol 77, pg 1147, 1998), PHIL MAG A, 81(12), 2001, pp. 2925-2925
Authors:
Hasegawa, K
Hashimoto, E
Kanai, N
Ogawa, M
Naritomi, T
Taniai, M
Takasaki, K
Hayashi, N
Citation: K. Hasegawa et al., Living-related partial liver transplantation for decompensated hepatitis Bwithout reactivation of hepatitis B in the following 30 months, J GASTRO, 36(9), 2001, pp. 637-642
Authors:
Shichinohe, S
Ozawa, H
Hashimoto, E
Tatschner, T
Riederer, P
Saito, T
Citation: S. Shichinohe et al., Changes in the cAMP-related signal transduction mechanism in postmortem human brains of heroin addicts, J NEURAL TR, 108(3), 2001, pp. 335-347
Authors:
Ogita, T
Hashimoto, E
Yamasaki, M
Nakaoka, T
Matsuoka, R
Kira, Y
Fujita, T
Citation: T. Ogita et al., Hypoxic induction of adrenomedullin in cultured human umbilical vein endothelial cells, J HYPERTENS, 19(3), 2001, pp. 603-608
Authors:
Haruta, I
Kato, Y
Hashimoto, E
Minjares, C
Kennedy, S
Uto, H
Yamauchi, K
Kobayashi, M
Yusa, S
Muller, U
Hayashi, N
Miyazaki, T
Citation: I. Haruta et al., Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages, J BIOL CHEM, 276(25), 2001, pp. 22910-22914
Authors:
Goto, N
Muto, S
Sugimoto, I
Ikawa-Kitayama, K
Igarashi, K
Ito, S
Hashimoto, E
Citation: N. Goto et al., A serpin with M-r 43,000 is a binding protein of M-r 25,000 protein, a substrate for protein Ser/Thr kinase detected in Xenopus laevis oocytes, J BIOCHEM, 129(2), 2001, pp. 229-236
Citation: K. Uchiyama et al., Highly precise bit-phase synchronization technique for an optically controlled time-division demultiplexer, IEEE PHOTON, 12(7), 2000, pp. 915-917
Authors:
Shiratori, Y
Moriyama, M
Imazeki, F
Ohkubo, H
Tanaka, N
Arakawa, Y
Yoshida, H
Yokosuka, O
Shibuya, A
Matsuzaki, K
Hashimoto, E
Hayashi, N
Hirata, K
Ohashi, Y
Omata, M
Citation: Y. Shiratori et al., A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients, LIVER, 20(4), 2000, pp. 271-280
Authors:
Mizuno, K
Nagai, S
Tamiya, A
Noda, Y
Okitsu, K
Hashimoto, E
Kino, T
Citation: K. Mizuno et al., Identification of nature of dislocation loops grown as vacancy source after up-quenching, JPN J A P 1, 38, 1999, pp. 460-463
Authors:
Sato, S
Fuchinoue, S
Abe, M
Kitajima, K
Tojimbara, T
Nakajima, I
Agishi, T
Shiraga, H
Ito, K
Takasaki, K
Hashimoto, E
Hayashi, N
Tanaka, K
Citation: S. Sato et al., Successful cytokine treatment of aplastic anemia following living-related orthotopic liver transplantation for non-A, non-B, non-C hepatitis, CLIN TRANSP, 13(1), 1999, pp. 68-71
Authors:
Toyoda, S
Miyagawa, H
Kitamura, K
Amisaki, T
Hashimoto, E
Ikeda, H
Kusumi, A
Miyakawa, N
Citation: S. Toyoda et al., Development of MD engine: High-speed accelerator with parallel processor design for molecular dynamics simulations, J COMPUT CH, 20(2), 1999, pp. 185-199
Authors:
Tokumoto, T
Tanabe, K
Ishikawa, N
Simizu, T
Oshima, T
Noguchi, S
Gouya, N
Nakazawa, H
Hashimoto, E
Fuchinoue, S
Hayashi, N
Toma, H
Citation: T. Tokumoto et al., Effect of interferon-alpha treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C, TRANSPLAN P, 31(7), 1999, pp. 2887-2889
Authors:
Sato, S
Fuchinoue, S
Abe, M
Kitajima, K
Tojimbara, T
Nakajima, I
Agishi, T
Shiraga, H
Ito, K
Takasaki, K
Hashimoto, E
Hayashi, N
Tanaka, K
Citation: S. Sato et al., Successful cytokine treatment of aplastic anemia following living-related orthotopic liver transplantation for non-A, non-B, non-C hepatitis, TRANSPLAN P, 31(1-2), 1999, pp. 521-522
Authors:
Tsuji, A
Hashimoto, E
Ikoma, T
Taniguchi, T
Mori, K
Nagahama, M
Matsuda, Y
Citation: A. Tsuji et al., Inactivation of proprotein convertase, PACE4, by alpha 1-antitrypsin Portland (alpha 1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: Evidence that PACE4 is able to form an SDS-stable acyl intermediate with alpha 1-PDX, J BIOCHEM, 126(3), 1999, pp. 591-603